2-Ethoxy-4-(trifluoromethyl)-1,3-thiazole-5-carboxylic acid, 1g

1-(3,5-Dichlorophenyl)-2-thiourea, 95.0%, 1g

N-Methyl-3-oxetaneamine, 95.0%, 250mg

6-(4-BROMOPHENYL)-2-(TRIFLUOROMETHYL)IMIDAZO[2,1-B][1,3,4]THIADIAZOLE, 95.0%, 250mg

5-Ethyl-2,2-dimethyl-1,3-dioxane-5-carboxylic acid, 97.0%, 250mg

Antimony powder, min. 99.5%, <100 mesh, 250 g, plastic packaging.

TRANS (+/-) (4-(4-METHYLPHENYL)PYRROLIDIN-3-YL)CARBAMIC ACID TERT-BUTYL ESTER, 95.0%, 250mg

Cyclopropyl-(2,3-dichloro-benzyl)-amine, 1g

1-Chloro-4-iodoisoquinoline, 95.0%, 1g

(S)-(+)-1,2,3,4-Tetrahydro-1-naphthylamine>98.0%(GC)(T)5g

Methyl 1-(6-chloropyrimidin-4-yl)piperidine-4-carboxylate, 95+%, 1g

(Benzo[1,3]dioxol-5-yloxy)-acetic acid, 95.0%, 5g

2-Bromo-9,9-difluoro-7-iodo-9H-fluorene>96.0%(GC)200mg